Visceral osteopathic manipulative treatment reduces patient reported digestive toxicities induced by adjuvant chemotherapy in breast cancer: A randomized controlled clinical study.

Fiche publication

Date publication

août 2019

Journal

European journal of obstetrics, gynecology, and reproductive biology

Auteurs

Membres identifiés du Cancéropôle Est :
Dr BERTAUT Aurélie , Dr COUDERT Bruno , Dr DESMOULINS Isabelle , Dr HENNEQUIN Audrey

Tous les auteurs :
Lagrange A, Decoux D, Briot N, Hennequin A, Coudert B, Desmoulins I, Bertaut A

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/31430616

Résumé

Breast cancer patients often benefit from adjuvant chemotherapy, a protocol whose effectiveness is accompanied by disabling adverse effects. The aim of this controlled clinical study was to determine the impact of visceral osteopathy on the incidence of nausea/vomiting, constipation and overall quality of life (QoL) in women operated for breast cancer and undergoing adjuvant chemotherapy in Centre Georges François Leclerc, CGFL.